Diabetic kidney disease — SCE Endocrinology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Finerenone
Finerenone can be considered in type 2 diabetes with chronic kidney disease and albuminuria despite optimised standard care, subject to potassium and formulary criteria. Spironolactone is not a routine albuminuria drug and has greater hyperkalaemia/endocrine adverse-effect concerns. Albuminuria is a risk marker and treatment target, not merely a finding to observe.
Reference: NICE TA877; NICE NG203